Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA opens new path for earlier-stage Alzheimers drugs

      FDA opens new path for earlier-stage Alzheimer's drugs

      Ruby Khatun Khatun18 Feb 2018 10:00 AM IST
      U.S. regulators have proposed lowering the bar for clinical trial success for experimental Alzheimer's drugs to better align with the current emphasis...
      Roche to buy Flatiron Health for 1.9 billion dollars to expand cancer care portfolio

      Roche to buy Flatiron Health for 1.9 billion dollars to expand cancer care portfolio

      Ruby Khatun Khatun18 Feb 2018 9:45 AM IST
      Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to speed...
      Oxford BioMedica wins second 100 million dollars gene therapy contract

      Oxford BioMedica wins second 100 million dollars gene therapy contract

      Ruby Khatun Khatun18 Feb 2018 9:30 AM IST
      LONDON: Britain’s Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed...
      Max Bupa launches a product for daily health needs

      Max Bupa launches a product for daily health needs

      Ruby Khatun Khatun18 Feb 2018 9:15 AM IST
      Mumbai: Standalone private sector health insurer Max Bupa has introduced a digitally enabled ‘everyday use’ health insurance plan that has been...
      USFDA completes inspection of Natco’s mekaguda API facility

      USFDA completes inspection of Natco’s mekaguda API facility

      Ruby Khatun Khatun17 Feb 2018 12:45 PM IST
      Natco Pharma Limited has announced the successful completion of regulatory inspection from the United States Food and Drug Administration (USFDA) for...
      SMT announces completion of patient enrolment of EverOCT Trial

      SMT announces completion of patient enrolment of EverOCT Trial

      Ruby Khatun Khatun17 Feb 2018 12:15 PM IST
      Mumbai: SMT has announced the enrolment completion of EverOCT – Tetrilimus Optical Coherence Tomography (OCT) Study.EverOCT study aims to evaluate the...
      Aster DM Healthcare IPO subscribed 1.3 times on final day

      Aster DM Healthcare IPO subscribed 1.3 times on final day

      Ruby Khatun Khatun17 Feb 2018 10:30 AM IST
      United Arab Emirates-based Aster DM Healthcare Ltd’s initial public offering (IPO) of shares on the Indian exchanges to raise 9.80 billion rupees...
      SETBACK: Merck, Pfizers immunotherapy fails in lung cancer trial

      SETBACK: Merck, Pfizer's immunotherapy fails in lung cancer trial

      Ruby Khatun Khatun17 Feb 2018 10:15 AM IST
      FRANKFURT: Merck KGaA and Pfizer received a setback for their drug Bavencio, which is a late starter in the rapidly evolving field of cancer...
      vTitan launches next-generation medical devices in India

      vTitan launches next-generation medical devices in India

      Ruby Khatun Khatun17 Feb 2018 10:00 AM IST
      Chennai: vTitan Corporation, a global medical device manufacturer and solutions provider, officially launched their patented Accuflow SP-550 and...
      Bayer gets FDA rebuke for drug production in Germany

      Bayer gets FDA rebuke for drug production in Germany

      Ruby Khatun Khatun17 Feb 2018 9:30 AM IST
      FRANKFURT: Bayer said it had received a warning letter from the U.S. Food and Drug Administration over how it handled production of some drugs at its...
      9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order

      9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order

      Ruby Khatun Khatun16 Feb 2018 3:52 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      SC allows financial institutions to sell pledged shares of Fortis Healthcare

      SC allows financial institutions to sell pledged shares of Fortis Healthcare

      Ruby Khatun Khatun16 Feb 2018 11:00 AM IST
      New Delhi: The Supreme Court said the financial institutions with whom shares of Fortis Healthcare Limited were pledged, can be sold or transferred by...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok